
What smart money is saying about Integer
2 funds in our archive have pitched Integer — most recently Artisan US Small Cap Growth Strategy in December 2024.
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Get an email when a fund writes about it
Position history
Between Q4 2024 and Q2 2026, 1 fund letter reported a position in Integer, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q4 2024 | 0 | 0 | 0 | 2 |
Fund activity · 1 position
- June 2026
“CONMED is expected to report a year-over-year revenue decline resulting from a recent divestiture, and Integer Holdings lowered its fiscal year 2026 revenue guidance, citing slower-than-expected growth in pulse field ablation products, causing shares of both companies to contract.”
Integer
Also mentioned · 1
These funds discuss Integer — as a competitor, benchmark or comparable — without disclosing a position in it.
- MentionedBoussard & Gavaudan Gestion Sas Market InsightsJuly 2026
“Meanwhile the announced acquisition of Integer Holdings by KKR at the end of the month further illustrates the strength of the current corporate activity environment.”
Integer
Fund coverage · 2 theses
- Artisan US Small Cap Growth StrategyDecember 2024
Integer is a leading manufacturer of medical devices with strong growth potential due to its focus on high-margin implantable devices and transcatheter therapies, benefiting from market trends and operational efficiency.
Read the full thesis - Riverwater Small CapDecember 2024
Integer Holdings Corporation (ITGR) is a leading medical device outsourcing manufacturer with a strong track record of revenue and earnings growth, making it well-positioned for stock appreciation.
Read the full thesis
Read every full thesis on Integer
Unlock all 2 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→